Source: Journal of hematology & oncology. Unidade: FM
Subjects: LEUCEMIA MIELOIDE AGUDA, CÉLULAS-TRONCO, CORDÃO UMBILICAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIANNOTTI, Federica et al. Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine. Journal of hematology & oncology, v. 11, 2018Tradução . . Disponível em: https://doi.org/10.1186/s13045-018-0655-8. Acesso em: 03 out. 2024.APA
Giannotti, F., Labopin, M., Shouval, R., Sanz, J., Arcese, W., Angelucci, E., et al. (2018). Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine. Journal of hematology & oncology, 11. doi:10.1186/s13045-018-0655-8NLM
Giannotti F, Labopin M, Shouval R, Sanz J, Arcese W, Angelucci E, Sierra J, Santasusana J-MR, Santarone S, Rocha VG. Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine [Internet]. Journal of hematology & oncology. 2018 ; 11[citado 2024 out. 03 ] Available from: https://doi.org/10.1186/s13045-018-0655-8Vancouver
Giannotti F, Labopin M, Shouval R, Sanz J, Arcese W, Angelucci E, Sierra J, Santasusana J-MR, Santarone S, Rocha VG. Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine [Internet]. Journal of hematology & oncology. 2018 ; 11[citado 2024 out. 03 ] Available from: https://doi.org/10.1186/s13045-018-0655-8
